Skip to main content
SpringerLink
Log in

Modern Radiotherapy Techniques in Malignant Pleural Mesothelioma

  • Chapter
  • First Online:
Book cover Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies

  • 1079 Accesses

Abstract

Although being rare, malignant pleural mesothelioma (MPM) is highly associated with asbestos, and the incidence is high in case of asbestos exposure. Surgery is the first step in the treatment of MPM; however, even an extended surgery is not sufficient for the curative treatment. Moreover, it was shown to decrease the survival rate. Trimodality treatment is required, limited surgical approach with adjuvant chemotherapy and radiotherapy (RT). The main problem in the setting of MPM is local failure. MPM has a tendency to recur in previous drain sites. Despite the controversial studies, many authors recommend the prophylactic irradiation of the drain sites in order to decrease the local recurrence rate. Every patient with MPM should receive RT in the adjuvant setting. It can be administered in a very large range of techniques. More advanced technology has been shown to result in better target coverage with decreased rates of toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Connelly RR, Spirtas R, Myers MH, et al. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst. 1987;78:1053–60.

    CAS  PubMed  Google Scholar 

  2. Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479–95.

    Article  CAS  PubMed  Google Scholar 

  3. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med. 1992;34:718–21.

    CAS  PubMed  Google Scholar 

  5. Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res. 1991;51:2263–7.

    CAS  PubMed  Google Scholar 

  6. Antman KH, Corson JM, Li FP, et al. Malignant mesothelioma following radiation exposure. J Clin Oncol. 1983;1:695–700.

    CAS  PubMed  Google Scholar 

  7. Baris I, Simonato L, Artvinli M, et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey. Int J Cancer. 1987;39:10–7.

    Article  CAS  PubMed  Google Scholar 

  8. Baris YI, Sahin AA, Ozesmi M, et al. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia. Thorax. 1978;33:181–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. Erionite exposure and mesotheliomas in rats. Br J Cancer. 1985;51:727–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Baris B, Demir AU, Shehu V, et al. Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. J Environ Pathol Toxicol Oncol. 1996;15:183–9.

    CAS  PubMed  Google Scholar 

  11. Emri S, Demir A, Dogan M, et al. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett. 2002;127:251–7.

    Article  CAS  PubMed  Google Scholar 

  12. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29:2–17.

    Article  CAS  PubMed  Google Scholar 

  13. Roushdy-Hammady I, Siegel J, Emri S, et al. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 2001;357:444–5.

    Article  CAS  PubMed  Google Scholar 

  14. Pass HI, Hahn S, Vogelzang NJ, et al. Benign and malignant mesothelioma. In: DeVita V, Hellman S, editors. Cancer: principles and practice of oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1937–64.

    Google Scholar 

  15. Edwards JG, Abrams KR, Leverment JN, et al. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax. 2000;55:731–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yildirim H, Metintas M, Entok E, et al. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. J Thorac Oncol. 2009;4:1480–4.

    Article  PubMed  Google Scholar 

  17. Benard F, Sterman D, Smith RJ, et al. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med. 1999;40:1241–5.

    CAS  PubMed  Google Scholar 

  18. Wilcox BE, Subramaniam RM, Peller PJ, et al. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer. 2009;10:244–8.

    Article  PubMed  Google Scholar 

  19. Bueno R, Reblando J, Glickman J, et al. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. 2004;78:1774–6.

    Article  PubMed  Google Scholar 

  20. Rusch VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest. 1993;103:382S–4.

    Article  CAS  PubMed  Google Scholar 

  21. Treasure T, Utley M. Mesothelioma: benefit from surgical resection is questionable. J Thorac Oncol. 2007;2:885–6.

    Article  PubMed  Google Scholar 

  22. Calavrezos A, Koschel G, Husselmann H, et al. Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981–1985. Klin Wochenschr. 1988;66:607–13.

    Article  CAS  PubMed  Google Scholar 

  23. Pass HI, Kranda K, Temeck BK, et al. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol. 1997;4:215–22.

    Article  CAS  PubMed  Google Scholar 

  24. Weder W, Stahel RA, Bernhard J, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol. 2007;18:1196–202.

    Article  CAS  PubMed  Google Scholar 

  25. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2001;122:788–95.

    Article  CAS  PubMed  Google Scholar 

  26. Baldini EH. External beam radiation therapy for the treatment of pleural mesothelioma. Thorac Surg Clin. 2004;14:543–8.

    Article  PubMed  Google Scholar 

  27. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54–63; discussion 63–55.

    Article  CAS  PubMed  Google Scholar 

  28. Huncharek M, Kelsey K, Mark EJ, et al. Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital. Anticancer Res. 1996;16:1265–8.

    CAS  PubMed  Google Scholar 

  29. Treasure T, Waller D, Tan C, et al. The mesothelioma and radical surgery randomized controlled trial: the mars feasibility study. J Thorac Oncol. 2009;4:1254–8.

    Article  PubMed  Google Scholar 

  30. Okubo K, Sonobe M, Fujinaga T, et al. Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. 2009;57:585–90.

    Article  PubMed  Google Scholar 

  31. Tonoli S, Vitali P, Scotti V, et al. Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series. Radiother Oncol. 2011;101:311–5.

    Article  PubMed  Google Scholar 

  32. Baldini EH, Recht A, Strauss GM, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997;63:334–8.

    Article  CAS  PubMed  Google Scholar 

  33. Bricout PB, Engler MJ. Computerized tomography scanning and the planning of high-dose radiotherapy for pleural mesothelioma: a report of five patients. Int J Radiat Oncol Biol Phys. 1981;7:821–6.

    Article  CAS  PubMed  Google Scholar 

  34. Kutcher GJ, Kestler C, Greenblatt D, et al. Technique for external beam treatment for mesothelioma. Int J Radiat Oncol Biol Phys. 1987;13:1747–52.

    Article  CAS  PubMed  Google Scholar 

  35. Yajnik S, Rosenzweig KE, Mychalczak B, et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2003;56:1319–26.

    Article  PubMed  Google Scholar 

  36. Ahamad A, Stevens CW, Smythe WR, et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J. 2003;9:476–84.

    Article  PubMed  Google Scholar 

  37. Ahamad A, Stevens CW, Smythe WR, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2003;55:768–75.

    Article  PubMed  Google Scholar 

  38. Forster KM, Smythe WR, Starkschall G, et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys. 2003;55:606–16.

    Article  PubMed  Google Scholar 

  39. Rice DC, Stevens CW, Correa AM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2007;84:1685–92; discussion 1692–1683.

    Article  PubMed  Google Scholar 

  40. de Perrot M, Feld R, Cho BC, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27:1413–8.

    Article  PubMed  Google Scholar 

  41. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65:640–5.

    Article  PubMed  Google Scholar 

  42. Miles EF, Larrier NA, Kelsey CR, et al. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys. 2008;71:1143–50.

    Article  PubMed  Google Scholar 

  43. Rice DC, Smythe WR, Liao Z, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2007;69:350–7.

    Article  PubMed  Google Scholar 

  44. Flores RM, Riedel E, Donington JS, et al. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010;5:1649–54.

    Article  PubMed  Google Scholar 

  45. Hurmuz P, Akyol F, Selek U, Ozyigit G, Dogan R, Ozdemir N, Tastepe I, Kayi Cangir A, Kara M, Demirkazik F, Emri S. The efficiency and toxicity of hemithoracic radiotherapy after extra pleural pneumonectomy in malign pleural mesothelioma. Int J Hematol Oncol. 2010;1:20–6.

    Google Scholar 

  46. Carmichael J, Degraff WG, Gamson J, et al. Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol. 1989;25:527–34.

    Article  CAS  PubMed  Google Scholar 

  47. Gordon Jr W, Antman KH, Greenberger JS, et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982;8:19–25.

    Article  PubMed  Google Scholar 

  48. Allen AM, Den R, Wong JS, et al. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys. 2007;68:1366–74.

    Article  PubMed  Google Scholar 

  49. Rengan R, Bonner Millar LP, Thomas Jr CR. Uncommon thoracic tumors. In: Gunderson LL, Tepper J, editors. Clinical radiation oncology. 3rd ed. Philadelphia: Elsevier Saunders; 2012. p. 859–89.

    Chapter  Google Scholar 

  50. Alberts AS, Falkson G, Goedhals L, et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol. 1988;6:527–35.

    CAS  PubMed  Google Scholar 

  51. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol. 1990;13:4–9.

    Article  CAS  PubMed  Google Scholar 

  52. Maasilta P. Deterioration in lung function following hemithorax irradiation for pleural mesothelioma. Int J Radiat Oncol Biol Phys. 1991;20:433–8.

    Article  CAS  PubMed  Google Scholar 

  53. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg. 1991;102:1–9.

    CAS  PubMed  Google Scholar 

  54. van Ooijen B, Eggermont AM, Wiggers T. Subcutaneous tumor growth complicating the positioning of Denver shunt and intrapleural port-a-cath in mesothelioma patients. Eur J Surg Oncol. 1992;18:638–40.

    PubMed  Google Scholar 

  55. Munter MW, Thieke C, Nikoghosyan A, et al. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience. Lung Cancer. 2005;49 Suppl 1:S83–6.

    Article  PubMed  Google Scholar 

  56. Rosenzweig KE, Zauderer MG, Laser B, et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2012;83:1278–83.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Rimner A, Spratt DE, Zauderer MG, et al. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2014;90:394–401.

    Article  PubMed  Google Scholar 

  58. Minatel E, Trovo M, Polesel J, et al. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J Thorac Oncol. 2012;7:1862–6.

    Article  PubMed  Google Scholar 

  59. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol. 1989;7:1157–68.

    CAS  PubMed  Google Scholar 

  60. Law MR, Hodson ME, Turner-Warwick M. Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment. Eur J Respir Dis. 1984;65:162–8.

    CAS  PubMed  Google Scholar 

  61. Agarwal PP, Seely JM, Matzinger FR, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiology. 2006;241:589–94.

    Article  PubMed  Google Scholar 

  62. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995;108:754–8.

    Article  CAS  PubMed  Google Scholar 

  63. O’Rourke N, Garcia JC, Paul J, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol. 2007;84:18–22.

    Article  PubMed  Google Scholar 

  64. Muirhead R, O’Rourke N. Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource. Eur Respir J. 2007;30:1021.

    Article  CAS  PubMed  Google Scholar 

  65. Chapman E, Berenstein EG, Dieguez M, Ortiz Z. Radiotherapy for malignant pleural mesothelioma. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD003880. doi:10.1002/14651858.CD003880.pub4.

  66. Bydder S, Phillips M, Joseph DJ, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer. 2004;91:9–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey. Radiother Oncol. 2003;68:299–302.

    Article  PubMed  Google Scholar 

  68. Lee C, Bayman N, Swindell R, Faivre-Finn C. Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice. Lung Cancer. 2009;66:150–6.

    Article  PubMed  Google Scholar 

  69. Janssen-Heijnen ML, Damhuis RA, Klinkhamer PJ, et al. Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population-based study. Eur J Cancer Prev. 1999;8:311–4.

    Article  CAS  PubMed  Google Scholar 

  70. Clive AO, Wilson P, Taylor H, et al. Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases. BMJ Open. 2015;5:e006673.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Gupta V, Mychalczak B, Krug L, et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2005;63:1045–52.

    Article  PubMed  Google Scholar 

  72. Hill-Kayser CE, Avery S, Mesina CF, et al. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques. J Thorac Oncol. 2009;4:1431–7.

    Article  PubMed  Google Scholar 

  73. Buduhan G, Menon S, Aye R, et al. Trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2009;88:870–5; discussion 876.

    Article  PubMed  Google Scholar 

  74. Price A. What is the role of radiotherapy in malignant pleural mesothelioma? Oncologist. 2011;16:359–65.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Cho BC, Feld R, Leighl N, et al. A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the “SMART” approach for resectable malignant pleural mesothelioma. J Thorac Oncol. 2014;9:397–402.

    Article  PubMed  Google Scholar 

  76. Gomez DR, Hong DS, Allen PK, et al. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol. 2013;8:238–45.

    Article  PubMed  Google Scholar 

  77. Patel PR, Yoo S, Broadwater G, et al. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83:362–8.

    Article  PubMed  Google Scholar 

  78. Rosenzweig KE. Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2013;25:245–50.

    Article  PubMed  Google Scholar 

  79. Du KL, Both S, Friedberg JS, et al. Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma. Cancer Biol Ther. 2010;10:425–9.

    Article  CAS  PubMed  Google Scholar 

  80. Allen AM, Schofield D, Hacker F, et al. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. Int J Radiat Oncol Biol Phys. 2007;69:1587–92.

    Article  PubMed  Google Scholar 

  81. Zhu XR, Prado K, Liu HH, et al. Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency. Int J Radiat Oncol Biol Phys. 2005;62:1525–34.

    Article  PubMed  Google Scholar 

  82. Jang SY, Liu HH, Mohan R. Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;71:1537–46.

    Article  PubMed  Google Scholar 

  83. Chi A, Liao Z, Nguyen NP, et al. Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol. 2011;6:1132–41.

    Article  PubMed  Google Scholar 

  84. Fenwick JD, Tome WA, Soisson ET, et al. Tomotherapy and other innovative IMRT delivery systems. Semin Radiat Oncol. 2006;16:199–208.

    Article  PubMed  Google Scholar 

  85. Chen AM, Marsano J, Perks J, et al. Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy “better” than step-and-shoot IMRT? Technol Cancer Res Treat. 2011;10:171–7.

    CAS  PubMed  Google Scholar 

  86. Chen YJ, Liu A, Han C, et al. Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim. 2007;32:166–71.

    Article  PubMed  Google Scholar 

  87. Sterzing F, Sroka-Perez G, Schubert K, et al. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT. Radiother Oncol. 2008;86:251–7.

    Article  PubMed  Google Scholar 

  88. Giraud P, Sylvestre A, Zefkili S, et al. Helical tomotherapy for resected malignant pleural mesothelioma: dosimetric evaluation and toxicity. Radiother Oncol. 2011;101:303–6.

    Article  PubMed  Google Scholar 

  89. Sylvestre A, Mahe MA, Lisbona A, et al. Mesothelioma at era of helical tomotherapy: results of two institutions in combining chemotherapy, surgery and radiotherapy. Lung Cancer. 2011;74:486–91.

    Article  PubMed  Google Scholar 

  90. Helou J, Clement-Colmou K, Sylvestre A, et al. Helical tomotherapy in the treatment of malignant pleural mesothelioma: the impact of low doses on pulmonary and oesophageal toxicity. Cancer Radiother. 2013;17:755–62.

    Article  CAS  PubMed  Google Scholar 

  91. Krayenbuehl J, Dimmerling P, Ciernik IF, Riesterer O. Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma. Radiat Oncol. 2014;9:32.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Scorsetti M, Bignardi M, Clivio A, et al. Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a feasibility study. Int J Radiat Oncol Biol Phys. 2010;77:942–9.

    Article  PubMed  Google Scholar 

  93. Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst. 1992;84:155–64.

    Article  CAS  PubMed  Google Scholar 

  94. Krayenbuehl J, Hartmann M, Lomax AJ, et al. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. Int J Radiat Oncol Biol Phys. 2010;78:628–34.

    Article  PubMed  Google Scholar 

  95. Lorentini S, Amichetti M, Spiazzi L, et al. Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment. Strahlenther Onkol. 2012;188:216–25.

    Article  CAS  PubMed  Google Scholar 

  96. Pan HY, Jiang S, Sutton J, et al. Early experience with intensity modulated proton therapy for lung-intact mesothelioma: a case series. Pract Radiat Oncol. 2015;5:e345–53.

    Article  PubMed  Google Scholar 

  97. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res. 1999;151:1–18.

    Article  CAS  PubMed  Google Scholar 

  98. Suzuki M, Sakurai Y, Masunaga S, et al. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis. Int J Radiat Oncol Biol Phys. 2006;66:1584–9.

    Article  PubMed  Google Scholar 

  99. Suzuki M, Sakurai Y, Masunaga S, et al. A preliminary experimental study of boron neutron capture therapy for malignant tumors spreading in thoracic cavity. Jpn J Clin Oncol. 2007;37:245–9.

    Article  PubMed  Google Scholar 

  100. Suzuki M, Endo K, Satoh H, et al. A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT). Radiother Oncol. 2008;88:192–5.

    Article  PubMed  Google Scholar 

  101. Patel SA, Kusano AS, Truong A, et al. Fast neutron radiotherapy in the treatment of malignant pleural mesothelioma. Am J Clin Oncol. 2015;38:47–50.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Gokhan Ozyigit MD, Pervin Hurmuz MD, Sezin Yuce Sari MD, Gozde Yazici MD & Melis Gultekin MD

Authors
  1. Gokhan Ozyigit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pervin Hurmuz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sezin Yuce Sari MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gozde Yazici MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melis Gultekin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pervin Hurmuz MD .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Hacettepe University, Faculty of Med., Ankara, Turkey

    Gokhan Ozyigit

  2. Department of Radiation Oncology, Koc University, Faculty of Medicine, Istanbul, Turkey

    Ugur Selek

  3. Department of Radiation Oncology, Baskent University School of Medicine, Adana, Turkey

    Erkan Topkan

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ozyigit, G., Hurmuz, P., Sari, S.Y., Yazici, G., Gultekin, M. (2016). Modern Radiotherapy Techniques in Malignant Pleural Mesothelioma. In: Ozyigit, G., Selek, U., Topkan, E. (eds) Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-319-28761-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28761-4_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28759-1

  • Online ISBN: 978-3-319-28761-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation